A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer treatments

Therapeutic drug synergism intervened in cancer treatments has been demonstrated to be more effective than using a single effector. However, it remains inherently challenging, with a limited cell count from tumor samples, to achieve potent personalized drug cocktails. To address the issue above, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ching-Te, Wang, Jong-Yueh, Lu, Siang-Rong, Lai, Yu-Sheng, Chang, Hsiu-Hao, Hsieh, Jer-Tsong, Wo, Andrew M., Chen, Benjamin P. C., Lu, Jen-Her, Lee, Hsinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625988/
https://www.ncbi.nlm.nih.gov/pubmed/31300742
http://dx.doi.org/10.1038/s41598-019-46502-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625988/
https://www.ncbi.nlm.nih.gov/pubmed/31300742
http://dx.doi.org/10.1038/s41598-019-46502-3

Ejemplares similares